A Short Progressive Supranuclear Palsy Quality of Life Scale
- PMID: 39056204
- DOI: 10.1002/mds.29936
A Short Progressive Supranuclear Palsy Quality of Life Scale
Abstract
Objective: The Progressive Supranuclear Palsy quality of life scale (PSP-QoL) has been shown to be a useful tool for capturing health-related quality of life of patients in "everyday life" and in progressive supranuclear palsy (PSP) research. However, at 45 items in length, the questionnaire can take a long time, exhausting PSP patients, in particular if cognitive impaired, which can have a negative impact on the assessment. The aim of this study was to establish a condensed version of the PSP-QoL for research and routine clinical care.
Methods: In this retrospective study, data originating from a German cohort of PSP patients was analyzed. Data from 245 PSP patients were included in this study. The short PSP-QoL questionnaire was created using a two-factor solution and item-total and inter-item correlations for mental and physical aspects of daily living of the PSP-QoL followed by confirmatory factor analysis.
Results: The final scale included 12 items representing mental (five items) and physical symptoms (seven items). The specified two-factor model displayed an excellent fit in the confirmatory factor analysis. The short Progressive Supranuclear Palsy Quality of Life scale (PSP-ShoQoL) correlated moderately with the PSP Rating Scale (r [243] = 0.514, P < 0.001) and Geriatric depression scale (r [231] = 0.548, P < 0.001). Sensitivity to change confirmed a significant decrease in QoL after 12 months.
Discussion: In this study, we created a 12-item PSP-ShoQoL designed to "facilitate" daily clinical work that correlated strongly with the PSP-QoL and was sensitive to change. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Keywords: PSP Quality of Life scale; health‐related quality of life; progressive supranuclear palsy; rating scale.
© 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
References
-
- Höglinger GU, Respondek G, Stamelou M, et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 2017;32(6):853–864.
-
- Levin J, Kurz A, Arzberger T, Giese A, Höglinger GU. Differenzial diagnose und Therapie der atypischen Parkinson‐Syndrome. Dtsch Arztebl Int 2016;113(5):61–69.
-
- Schrag A, Selai C, Quinn N, Hobart J. Measuring health‐related quality of life in patients with progressive supranuclear palsy. Neurocase 2005;11(4):246–249.
-
- Schrag A, Selai C, Quinn N, et al. Measuring quality of life in PSP: the PSP‐QoL. Neurology 2006;67(1):39–44.
-
- Marinus J, Ramaker C, van Hilten JJ, Stiggelbout A. Health related quality of life in Parkinson's disease: a systematic review of disease specific instruments. J Neurol Neurosurg Psychiatry 2002;72(2):241–248.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
